Financials
- Market Capitalization 3.43 B
- Employee 624
- Founded 2009
- CEO Chad Robins
- Website www.adaptivebiotech.com
- Headquarter Washington, United States
- FIGI BBG001J2PFF5
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-41.64
市销率
8.9
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1613 | DYN Dyne Therapeutics, Inc. - Common Stock | 23.78 USD | +0.59% | -0.21% | +28.82% | +1.58% | 3.40 B USD | ||
| 1615 | ALMS Alumis Inc. - Common Stock | 27.28 USD | -2.92% | -6.80% | +11.85% | +504.88% | 3.37 B USD | ||
| 1619 | ARQT Arcutis Biotherapeutics, Inc. - Common stock | 26.81 USD | -1.14% | -3.11% | +8.90% | +68.19% | 3.35 B USD | ||
| 1656 | BEAM Beam Therapeutics Inc. - Common Stock | 30.92 USD | -0.26% | -18.52% | +3.58% | +44.89% | 3.18 B USD |